BRIEF-Protagonist Therapeutics Posts Q4 Loss Per Share Of $0.48
BRIEF-Protagonist Therapeutics Posts Q4 Loss Per Share Of $0.48
簡介-主角治療公司公佈第四季度每股虧損0.48美元
March 10 (Reuters) - Protagonist Therapeutics Inc :
* PROTAGONIST THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.48
* Q4 EARNINGS PER SHARE ESTIMATE $-0.48 -- REFINITIV IBES DATA
* CASH POSITION TO FUND PLANNED OPERATIONS THROUGH FIRST HALF OF 2024
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* PROTAGONIST THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.48
* Q4 EARNINGS PER SHARE ESTIMATE $-0.48 -- REFINITIV IBES DATA
* CASH POSITION TO FUND PLANNED OPERATIONS THROUGH FIRST HALF OF 2024
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
March 10 (Reuters) - Protagonist Therapeutics Inc :
* PROTAGONIST THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.48
* Q4 EARNINGS PER SHARE ESTIMATE $-0.48 -- REFINITIV IBES DATA
* CASH POSITION TO FUND PLANNED OPERATIONS THROUGH FIRST HALF OF 2024
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透3月10日電-主角治療公司:*Prodicant Treeutics報告2020年第四季度和全年財務業績和公司最新情況*第四季度每股虧損0.48美元*第四季度每股收益預估-0.48美元-REFINITIV IBES數據*現金狀況,為2024年上半年之前的計劃運營提供資金Eikon的源文本:進一步的公司報道:(Reurs.Briefs@thomsonreurs.com;)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
搶先評論
0 0 0
讚好勁正笑哭社會社會Emm惨惨嬲嬲
輕觸選擇心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧
點擊這裡與好友分享
暫無評論,快來留言吧!